SOLENO THERAPEUTICS INC (SLNO)
SEC fundamentals · as filed in 10-Q FY2026, period ended Mar 31, 2026 · updated Oct 7, 2026
as filed in 10-Q FY2026, period ended Mar 31, 2026 · View filings on EDGAR ↗
In its 10-Q for the period ended Mar 31, 2026, SOLENO THERAPEUTICS INC reported revenue of $94.6M, net income of $31.4M, and total assets of $608.4M. Every figure below is taken directly from SOLENO THERAPEUTICS INC's SEC filings: each links to the source document on EDGAR.
Revenue and net income by fiscal year
As reported in each year’s annual filing · USD
| Fiscal year | Revenue | Net income |
|---|---|---|
| FY2025 | $190.4M | $20.9M |
| FY2024 | — | -$175.8M |
| FY2023 | — | -$39.0M |
| FY2022 | — | -$24.1M |
| FY2021 | — | -$30.9M |
| FY2020 | — | -$24.6M |
| FY2019 | — | -$30.8M |
| FY2018 | — | -$13.3M |
| FY2017 | — | -$15.4M |
| FY2016 | $1.5M | -$12.1M |
Recent SEC filings
Filed by the registrant · newest first · insider forms and holder schedules not included
| Form | Filed | Source |
|---|---|---|
| 8-K | May 18, 2026 | on EDGAR ↗ |
| 10-Q | May 7, 2026 | on EDGAR ↗ |
| 10-K/A | Apr 30, 2026 | on EDGAR ↗ |
| 8-K | Apr 7, 2026 | on EDGAR ↗ |
| 8-K | Apr 6, 2026 | on EDGAR ↗ |
| 8-K | Mar 16, 2026 | on EDGAR ↗ |
| 8-K | Feb 26, 2026 | on EDGAR ↗ |
| 8-K | Feb 25, 2026 | on EDGAR ↗ |
| 10-K | Feb 25, 2026 | on EDGAR ↗ |
| 8-K | Jan 23, 2026 | on EDGAR ↗ |
Balance Sheet
as of Mar 31, 2026 · 10-Q
Income Statement
10-Q (quarterly) · period ended Mar 31, 2026
| Revenue | $94.6M | Revenue | source ↗ |
| Net Income | $31.4M | Net | source ↗ |
| Operating Income | $31.3M | Operating | source ↗ |
| Gross Profit | $93.4M | Revenue−Cost | source ↗ |
| Cost of Revenue | $1.2M | Cost | source ↗ |
| R&D Expense | $11.3M | Research | source ↗ |
Per Share & Cash Flow
10-Q (quarterly) · period ended Mar 31, 2026
| EPS (diluted) | $0.59 | Earnings | source ↗ |
| EPS (basic) | $0.60 | Earnings | source ↗ |
| Shares Outstanding | 52.1M | Entity | source ↗ |
| Cash from Operations | $26.0M | Net | source ↗ |
| Cash from Financing | -$1.0M | Net | source ↗ |
| Cash from Investing | $38.0M | Net | source ↗ |
Insider activity
Form 4 open-market activity, last 180 days
No open-market Form 4 transactions filed in the last 180 days.
Restatement history
Point-in-time12 of 312 annual fact-keys were materially restated between filings: what SOLENO THERAPEUTICS INC first reported differed from what it later filed. We keep every vintage of every annual figure, each keyed to its EDGAR accession.
See each original-vs-restated value, and query any company as of any past date, with the point-in-time API.
Deeper fundamentals
A free API key reaches SLNO’s revenue, margin and free-cash-flow trajectory (newest 3 fiscal years) and its leverage, liquidity and return ratios (newest 4 quarters). Analyst extends those to up to 20 years and 20 quarters, and adds the Piotroski F-score and accruals quality score. As-of fundamentals at any past date are on Free too, up to 10 lookups a day; Analyst removes that cap and adds the original-vs-restated detail, across the whole SEC universe.
Programmatic access
Everything on this page is served by the Distill API and by the MCP server at mcp.distillmarkets.com. A free key is issued at sign-up with no card; the full reference is in the docs.
- These fundamentals, as filed
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/SLNO
MCP tool:
get_sec_fundamentals ticker=SLNO - The same figures as they were known on any past date
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/SLNO/as-of/YYYY-MM-DD
MCP tool:
get_asof_fundamentals ticker=SLNO as_of=YYYY-MM-DD - Fiscal-year trajectory: revenue, margins, free cash flow
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/fundamentals/SLNO/history
MCP tool:
get_fundamentals_history ticker=SLNO - Leverage, liquidity, margin and return ratios
- curlcurl -H "X-Api-Key: $DISTILL_API_KEY" \https://api.distillmarkets.com/api/v1/sec/financial-health/SLNO
MCP tool:
get_financial_health ticker=SLNO
Not investment advice. Figures are shown as filed with the SEC; see the EDGAR source links for the original documents. Data may lag the latest filing.